ExLibris header image
SFX Logo
Title: Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Hu, S L yr:1989


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Burton, D R R. "Why do we not have an HIV vaccine and how can we make one? ." Nature medicine 4.5: 495-498. Link to SFX for this item
2. Fauci, Anthony S. "HIV vaccine research: the way forward." Science 321.5888 (2008): 530-532. Link to SFX for this item
3. Nabel, Gary J J. "HIV vaccine strategies." Vaccine 20.15 (2002): 1945-7. Link to Full Text for this item Link to SFX for this item
4. Esparza, J. "Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?" The lancet (2000): 2061-6. Link to SFX for this item
5. Bredell, H. "HIV type 1 subtype C gag and nef diversity in Southern Africa." AIDS research and human retroviruses 23.3 (2007): 477-81. Link to SFX for this item
6. Hanke, T. "Is an HIV vaccine possible?" Nature medicine 5.6: 612-614. Link to SFX for this item
7. Johnston, Margaret I I. "An HIV vaccine--evolving concepts." The New England journal of medicine 356.20 (2007): 2073-81. Link to SFX for this item
8. Koff, Wayne C. "Accelerating HIV vaccine development." Nature 464.7286 (2010): 161-162. Link to Full Text for this item Link to SFX for this item
9. Cohen, J. "The Great Funding Surge." Science 321.5888 (2008): 512-519. Link to SFX for this item
10. Kiepiela, P. "CD8+ T-cell responses to different HIV proteins have discordant associations with viral load." Nature medicine 13.1 (2006): 46-53. Link to Full Text for this item Link to SFX for this item
11. Wyatt, Richard T T. "HIV vaccine design and the neutralizing antibody problem." Nature immunology 5.3 (2004): 233-6. Link to Full Text for this item Link to SFX for this item
12. Doria Rose, Nicole A. "A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies." Journal of virology 86.15 (2012): 8319-8323. Link to Full Text for this item Link to SFX for this item
13. McMichael, Andrew J. "HIV vaccines 1983–2003." Nature Medicine 9.7 (2003): 874-880. Link to Full Text for this item Link to SFX for this item
14. Thuku, R. "Post-translational cleavage of recombinantly expressed nitrilase from Rhodococcus rhodochrous J1 yields a stable, active helical form." The FEBS journal 274.8 (2007): 2099-2108. Link to Full Text for this item Link to SFX for this item
15. Klein, M. "AIDS and HIV vaccines." Vaccine 17 (1999): -70. Link to Full Text for this item Link to SFX for this item
16. Shinya Oishi, S. "Design of a Novel HIV-1 Fusion Inhibitor That Displays a Minimal Interface for Binding Affinity." Journal of medicinal chemistry 51.3 (2008): 388-391. Link to Full Text for this item Link to SFX for this item
17. Markel, H. "The Search for Effective HIV Vaccines." The New England journal of medicine 353.8 (2005): 753-757. Link to SFX for this item
18. Duerr, A. "HIV vaccines: new frontiers in vaccine development." Clinical infectious diseases 43.4 (2006): 500-11. Link to SFX for this item
19. Koff, Wayne C C. "HIV vaccine design: insights from live attenuated SIV vaccines." Nature immunology 7.1: 19-23. Link to SFX for this item
20. Slack, C. "Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective." Social science & medicine 60.6: 1197-1208. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.